Kovack Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,109
| Closed | -$310K | – | 613 |
|
|
2024
Q3 | $310K | Sell |
12,109
-1,023
| -8% | -$26.2K | 0.03% | 431 |
|
|
2024
Q2 | $308K | Sell |
13,132
-1,079
| -8% | -$25.3K | 0.03% | 413 |
|
|
2024
Q1 | $409K | Sell |
14,211
-128
| -0.9% | -$3.68K | 0.05% | 292 |
|
|
2023
Q4 | $470K | Buy |
14,339
+466
| +3% | +$15.3K | 0.06% | 310 |
|
|
2023
Q3 | $387K | Buy |
13,873
+830
| +6% | +$23.1K | 0.05% | 322 |
|
|
2023
Q2 | $445K | Sell |
13,043
-221
| -2% | -$7.53K | 0.06% | 318 |
|
|
2023
Q1 | $399K | Buy |
13,264
+911
| +7% | +$27.4K | 0.05% | 335 |
|
|
2022
Q4 | $349K | Sell |
12,353
-230
| -2% | -$6.49K | 0.05% | 371 |
|
|
2022
Q3 | $414K | Sell |
12,583
-73
| -0.6% | -$2.4K | 0.06% | 326 |
|
|
2022
Q2 | $399K | Sell |
12,656
-613
| -5% | -$19.3K | 0.05% | 375 |
|
|
2022
Q1 | $609K | Sell |
13,269
-37
| -0.3% | -$1.7K | 0.06% | 338 |
|
|
2021
Q4 | $815K | Buy |
13,306
+6,492
| +95% | +$398K | 0.08% | 276 |
|
|
2021
Q3 | $509K | Buy |
6,814
+758
| +13% | +$56.6K | 0.06% | 374 |
|
|
2021
Q2 | $560K | Buy |
6,056
+1,140
| +23% | +$105K | 0.06% | 327 |
|
|
2021
Q1 | $436K | Buy |
+4,916
| New | +$436K | 0.06% | 349 |
|
|
2020
Q3 | – | Sell |
-4,939
| Closed | -$258K | – | 499 |
|
|
2020
Q2 | $258K | Sell |
4,939
-19,461
| -80% | -$1.02M | 0.05% | 351 |
|
|
2020
Q1 | $763K | Buy |
24,400
+349
| +1% | +$10.9K | 0.18% | 135 |
|
|
2019
Q4 | $806K | Buy |
24,051
+2,217
| +10% | +$74.3K | 0.14% | 169 |
|
|
2019
Q3 | $645K | Buy |
21,834
+14,920
| +216% | +$441K | 0.13% | 182 |
|
|
2019
Q2 | $238K | Buy |
+6,914
| New | +$238K | 0.05% | 354 |
|
|
2018
Q2 | – | Sell |
-10,204
| Closed | -$263K | – | 415 |
|
|
2018
Q1 | $263K | Buy |
+10,204
| New | +$263K | 0.07% | 340 |
|